Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer
Miles, D W, de Haas, S L, Dirix, L Y, Romieu, G, Chan, A, Pivot, X, Tomczak, P, Provencher, L, Cortés, J, Delmar, P R, Scherer, S J
Published in British journal of cancer (19.03.2013)
Published in British journal of cancer (19.03.2013)
Get full text
Journal Article
Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials
Sunakawa, Y., Stintzing, S., Cao, S., Heinemann, V., Cremolini, C., Falcone, A., Yang, D., Zhang, W., Ning, Y., Stremitzer, S., Matsusaka, S., Yamauchi, S., Parekh, A., Okazaki, S., Berger, M.D., Graver, S., Mendez, A., Scherer, S.J., Loupakis, F., Lenz, H.-J.
Published in Annals of oncology (01.12.2015)
Published in Annals of oncology (01.12.2015)
Get full text
Journal Article
Discovery and development of novel therapies in advanced breast cancer: rapid development of ribociclib
Germa, C., Miller, M., Mukhopadhyay, P., Hewes, B., Caponigro, G., Scherer, S.J., Hirawat, S.
Published in Annals of oncology (01.08.2017)
Published in Annals of oncology (01.08.2017)
Get full text
Journal Article
Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer
Volz, N B, Stintzing, S, Zhang, W, Yang, D, Ning, Y, Wakatsuki, T, El-Khoueiry, R E, Li, J E, Kardosh, A, Loupakis, F, Cremolini, C, Falcone, A, Scherer, S J, Lenz, H-J
Published in The pharmacogenomics journal (01.02.2015)
Published in The pharmacogenomics journal (01.02.2015)
Get full text
Journal Article
Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility
Yang, Guohze, Scherer, Stefan J., Shell, Scarlet S., Yang, Kan, Kim, Mimi, Lipkin, Martin, Kucherlapati, Raju, Kolodner, Richard D., Edelmann, Winfried
Published in Cancer cell (01.08.2004)
Published in Cancer cell (01.08.2004)
Get full text
Journal Article
An Msh2 point mutation uncouples DNA mismatch repair and apoptosis
LIN, Diana P, YUXUN WANG, UMAR, Asad, KUCHERLAPATI, Raju, LIPKIN, Martin, KUNKEL, Thomas A, EDELMANN, Winfried, SCHERER, Stefan J, CLARK, Alan B, KAN YANG, AVDIEVICH, Elena, BO JIN, WERLING, Uwe, PARRIS, Tchaiko, KURIHARA, Naoto
Published in Cancer research (Chicago, Ill.) (15.01.2004)
Published in Cancer research (Chicago, Ill.) (15.01.2004)
Get full text
Journal Article
Examination of Msh6- and Msh3-deficient mice in class switching reveals overlapping and distinct roles of MutS homologues in antibody diversification
Li, Ziqiang, Scherer, Stefan J, Ronai, Diana, Iglesias-Ussel, Maria D, Peled, Jonathan U, Bardwell, Philip D, Zhuang, Min, Lee, KyeRyoung, Martin, Alberto, Edelmann, Winfried, Scharff, Matthew D
Published in The Journal of experimental medicine (05.07.2004)
Published in The Journal of experimental medicine (05.07.2004)
Get full text
Journal Article
p53 and c-Jun Functionally Synergize in the Regulation of the DNA Repair Gene hMSH2 in Response to UV
Scherer, Stefan J., Maier, Sandra M., Seifert, Markus, Hanselmann, Rainer G., Zang, Klaus D., Müller-Hermelink, Hans K., Angel, Peter, Welter, Cornelius, Schartl, Manfred
Published in The Journal of biological chemistry (01.12.2000)
Published in The Journal of biological chemistry (01.12.2000)
Get full text
Journal Article
A putative Sec23 homologue of Plasmodium falciparum is located in Maurer’s clefts
Wickert, Hannes, Rohrbach, Petra, Scherer, Stefan J., Krohne, Georg, Lanzer, Michael
Published in Molecular and biochemical parasitology (01.07.2003)
Published in Molecular and biochemical parasitology (01.07.2003)
Get full text
Journal Article
Specific in vitro binding of p53 to the promoter region of the human mismatch repair gene hMSH2
Scherer, S J, Welter, C, Zang, K D, Dooley, S
Published in Biochemical and biophysical research communications (25.04.1996)
Published in Biochemical and biophysical research communications (25.04.1996)
Get full text
Journal Article
Disposition of cyromazine in plants under environmental conditions
Lim, Lori O, Scherer, Susan J, Shuler, Kenneth D, Toth, John P
Published in Journal of agricultural and food chemistry (01.03.1990)
Published in Journal of agricultural and food chemistry (01.03.1990)
Get full text
Journal Article
Biomarkers of treatment benefit in a randomized phase II study of bevacizumab in combination with carboplatin and paclitaxel in metastatic melanoma patients (BEAM)
Hegde, P., Xing, B., O'Day, S., Kim, K. B., Schmidt, M., Scherer, S. J., Nguyen, H., Peterson, A. C., Cheverton, P., Chen, D. S.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Circulating vascular endothelial growth factor (VEGF) as a biomarker for bevacizumab-based therapy in metastatic colorectal, non-small cell lung, and renal cell cancers: Analysis of phase III studies
Bernaards, C., Hegde, P., Chen, D., Holmgren, E., Zheng, M., Jubb, A. M., Koeppen, H., Scherer, S. J., Chen, D. S.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Integrative and multidisciplinary clinical trial using imaging, molecular, and dynamic biomarkers to predict bevacizumab plus chemotherapy response in breast cancer
Lopez-Vega, J. M., Calvo, E. G., Plazaola, A., Hernando, B., Morales Murillo, S., Anton, A., Gomez, R. M. S., Alvarez, I., Illarramendi, J. J., De Juan, A., Martinez, P., Llombart, A., Scherer, S. J., Sabariz, L., la Huerta, A., Pina, L. J., Dominguez, I., Garcia Velloso, M. J., Boni, V., Garcia-Foncillas, J.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article